{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:18:24Z","timestamp":1793085504346,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.lfs.2020.117594","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T10:39:35Z","timestamp":1587033575000},"page":"117594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"special_numbering":"C","title":["Tuberculosis vaccine: A journey from BCG to present"],"prefix":"10.1016","volume":"252","author":[{"given":"Samreen","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjna","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gobardhan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved Prakash","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117594_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/146642400212200206","article-title":"The global emergency of tuberculosis: what is the cause?","volume":"122","author":"Grange","year":"2002","journal-title":"J R Soc. Promot. Health."},{"key":"10.1016\/j.lfs.2020.117594_bb0010","series-title":"WHO Reference Number: WHO\/CDS\/TB\/2019.15 Tuberculosis","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.lfs.2020.117594_bb0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.117594_bb0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0025","author":"World Health Organization"},{"key":"10.1016\/j.lfs.2020.117594_bb0030","first-page":"E9","article-title":"The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J Prev. Med. Hyg."},{"key":"10.1016\/j.lfs.2020.117594_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0033-8389(22)00609-1","article-title":"Tuberculosis. Captain of all these men of death","volume":"33","author":"Rubin","year":"1995","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.lfs.2020.117594_bb0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/civ452","article-title":"Development of BCG scar and subsequent morbidity and mortality in rural Guinea-Bissa","volume":"61","author":"Storgaard","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0045","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Buchar)."},{"key":"10.1016\/j.lfs.2020.117594_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2005.06.002","article-title":"Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates","volume":"10","author":"Paredes","year":"2006","journal-title":"Int. Jour. Inf. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.00113413","article-title":"Bacille Calmette\u2013Gu\u00e9rin vaccination: the current situation in Europe","volume":"43","author":"Dara","year":"2014","journal-title":"European Resp. Journl."},{"key":"10.1016\/j.lfs.2020.117594_bb0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nature Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0041-3879(36)80249-9","article-title":"Tuberculosis in hospital nurses","volume":"18","author":"Heimbeck","year":"1936","journal-title":"Tubercle."},{"key":"10.1016\/j.lfs.2020.117594_bb0070","first-page":"255","article-title":"Protective vaccination against tuberculosis with special reference to BCG vaccination","volume":"58","author":"Aronson","year":"1948","journal-title":"American Review of Tuberculosis."},{"key":"10.1016\/j.lfs.2020.117594_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","article-title":"BCG vaccination of Indian infants in Saskatchewan","volume":"30","author":"Ferguson","year":"1949","journal-title":"Tubercle."},{"key":"10.1016\/j.lfs.2020.117594_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jama.1948.02890190001001","article-title":"BCG vaccination in all age groups; methods and results of a strictly controlled study","volume":"136","author":"Rosenthal","year":"1948","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.lfs.2020.117594_bb0085","first-page":"491","article-title":"A brief history of vaccines & vaccination in India","volume":"139","author":"Lahariya","year":"2014","journal-title":"Indian J Med Res."},{"key":"10.1016\/j.lfs.2020.117594_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.lfs.2020.117594_bb0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG \u2014 implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nature Reviews Microbiology."},{"key":"10.1016\/j.lfs.2020.117594_bb0100","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev. Inf. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0105","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"The Lancet."},{"key":"10.1016\/j.lfs.2020.117594_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun."},{"key":"10.1016\/j.lfs.2020.117594_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrmicro1538","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nature Reviews Microbiology."},{"key":"10.1016\/j.lfs.2020.117594_bb0120","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2020.117594_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai","year":"2016","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.lfs.2020.117594_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-065X.2008.00702.x","article-title":"The role of cytokines in the initiation, expansion,and control of cellular immunity to tuberculosis","volume":"226","author":"Cooper","year":"2008","journal-title":"Immunol Rev."},{"key":"10.1016\/j.lfs.2020.117594_bb0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol Rev."},{"key":"10.1016\/j.lfs.2020.117594_bb0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine."},{"key":"10.1016\/j.lfs.2020.117594_bb0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature07781","article-title":"Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation","volume":"458","author":"Torchinsky","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2020.117594_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity."},{"key":"10.1016\/j.lfs.2020.117594_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1369-5274(99)80015-0","article-title":"T cell mediated immunity to Mycobacterium tuberculosis","volume":"2","author":"Stenger","year":"1999","journal-title":"Current Opinion in Microbiology."},{"key":"10.1016\/j.lfs.2020.117594_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.117594_bb0165","doi-asserted-by":"crossref","first-page":"e0190989","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"Plos One"},{"key":"10.1016\/j.lfs.2020.117594_bb0170","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol."},{"key":"10.1016\/j.lfs.2020.117594_bb0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.lfs.2020.117594_bb0180","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2017.01803","article-title":"MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic","volume":"8","author":"Jesus","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.117594_bb0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis."},{"key":"10.1016\/j.lfs.2020.117594_bb0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2051013615593891","article-title":"Recent advances in the development of vaccines for tuberculosis","volume":"3","author":"Ahsan","year":"2015","journal-title":"Ther Adv Vaccines."},{"key":"10.1016\/j.lfs.2020.117594_bb0195","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01 vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.coi.2010.04.006","article-title":"Novel tuberculosis vaccines on the horizon","volume":"22","author":"Parida","year":"2010","journal-title":"Current Opinion in Immuno."},{"key":"10.1016\/j.lfs.2020.117594_bb0205","first-page":"190","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117594_bb0210","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.lfs.2020.117594_bb0215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/cid\/ciu331","article-title":"BCG, latitude, and environmental mycobacteria","volume":"59","author":"Reyn","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0220","first-page":"470","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2020.117594_bb0225","first-page":"363","article-title":"Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca mulatta) against airborne tuberculosis","volume":"143","author":"Anacker","year":"1972","journal-title":"Z. F\u00fcr Immun. Exp Klin Immunol."},{"key":"10.1016\/j.lfs.2020.117594_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2020.117594_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nature Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int. Jour. Inf. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0255","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/s41598-017-03514-1","article-title":"Efficacy and safety of Mycobacterium indicus pranii as an adjunct therapy in category II pulmonary tuberculosis in a randomized trial","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.117594_bb0260","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1080\/21645515.2017.1335374","article-title":"Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Huang","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2020.117594_bb0265","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2020.117594_bb0270","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/infdis\/jiw467","article-title":"Induction of an immunoprotective T-cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in humans","volume":"214","author":"Jeyanathan","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117594_bb0275","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial","volume":"6","author":"Nicholson","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.117594_bb0285","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.lfs.2020.117594_bb0290","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Meeren","year":"2018","journal-title":"N. Engl. J. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520303428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520303428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:35:57Z","timestamp":1758400557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520303428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":56,"alternative-id":["S0024320520303428"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117594","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis vaccine: A journey from BCG to present","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117594"}}